Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.


Volunteer for Ebola Vaccine Trial Says It’s ‘Worth It'

120 volunteers take part in a Swiss trial for an experimental Ebola vaccine developed by GlaxoSmithKline.

Best of NBC News

Play All